Profile | GDS5420 / 206781_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 31.86 | 25 |
GSM1296119 | B_lesional_pre-dose | 59.26 | 31 |
GSM1296076 | C_lesional_pre-dose | 70.43 | 36 |
GSM1296092 | D_lesional_pre-dose | 56.99 | 35 |
GSM1296103 | E_lesional_pre-dose | 39.75 | 28 |
GSM1296078 | F_lesional_pre-dose | 52.11 | 32 |
GSM1296107 | G_lesional_pre-dose | 82.3 | 37 |
GSM1296109 | H_lesional_pre-dose | 38.93 | 25 |
GSM1296080 | I_lesional_pre-dose | 48.28 | 32 |
GSM1296090 | J_lesional_pre-dose | 45.5 | 31 |
GSM1296074 | K_lesional_pre-dose | 70.27 | 39 |
GSM1296111 | L_lesional_pre-dose | 73.8 | 34 |
GSM1296099 | M_lesional_pre-dose | 53.51 | 32 |
GSM1296086 | O_lesional_pre-dose | 56.32 | 34 |
GSM1296117 | P_lesional_pre-dose | 71.39 | 34 |
GSM1296113 | Q_lesional_pre-dose | 104.95 | 39 |
GSM1296096 | R_lesional_pre-dose | 54.84 | 33 |
GSM1296105 | S_lesional_pre-dose | 43.68 | 28 |
GSM1296098 | T_lesional_pre-dose | 11.02 | 8 |
GSM1296101 | U_lesional_pre-dose | 19.65 | 18 |
GSM1296121 | V_lesional_pre-dose | 41.91 | 27 |
GSM1296088 | W_lesional_pre-dose | 49.34 | 32 |
GSM1296082 | X_lesional_pre-dose | 42.51 | 30 |
GSM1296115 | Y_lesional_pre-dose | 82.74 | 37 |
GSM1296084 | Z_lesional_pre-dose | 54.11 | 32 |
GSM1296072 | B_lesional_day8 | 52.18 | 30 |
GSM1296069 | L_lesional_day8 | 75.77 | 34 |
GSM1296071 | P_lesional_day8 | 69.38 | 32 |
GSM1296070 | Y_lesional_day8 | 74.16 | 34 |
GSM1296073 | V_lesional_day8 | 69.11 | 35 |
GSM1296034 | A_lesional_day15 | 56.31 | 32 |
GSM1296041 | G_lesional_day15 | 71.4 | 34 |
GSM1296035 | R_lesional_day15 | 32.76 | 27 |
GSM1296038 | U_lesional_day15 | 51.59 | 32 |
GSM1296047 | B_lesional_day15 | 73.13 | 34 |
GSM1296039 | E_lesional_day15 | 45.63 | 29 |
GSM1296042 | H_lesional_day15 | 38.29 | 23 |
GSM1296043 | L_lesional_day15 | 70.94 | 33 |
GSM1296037 | M_lesional_day15 | 38.88 | 26 |
GSM1296046 | P_lesional_day15 | 79.18 | 35 |
GSM1296044 | Q_lesional_day15 | 72.1 | 33 |
GSM1296045 | Y_lesional_day15 | 80.7 | 34 |
GSM1296025 | C_lesional_day15 | 60.83 | 34 |
GSM1296033 | D_lesional_day15 | 58.3 | 34 |
GSM1296027 | I_lesional_day15 | 60.25 | 36 |
GSM1296032 | J_lesional_day15 | 54.65 | 32 |
GSM1296024 | K_lesional_day15 | 38.5 | 28 |
GSM1296031 | W_lesional_day15 | 63.67 | 34 |
GSM1296028 | X_lesional_day15 | 53.36 | 32 |
GSM1296029 | Z_lesional_day15 | 71.63 | 37 |
GSM1296026 | F_lesional_day15 | 51.49 | 31 |
GSM1296030 | O_lesional_day15 | 51.28 | 34 |
GSM1296040 | S_lesional_day15 | 53.22 | 31 |
GSM1296036 | T_lesional_day15 | 41.88 | 27 |
GSM1296048 | V_lesional_day15 | 57.87 | 31 |
GSM1296059 | A_lesional_day43 | 42.3 | 29 |
GSM1296066 | G_lesional_day43 | 66.79 | 33 |
GSM1296060 | R_lesional_day43 | 56.31 | 33 |
GSM1296063 | U_lesional_day43 | 42.29 | 28 |
GSM1296064 | E_lesional_day43 | 53.74 | 32 |
GSM1296067 | H_lesional_day43 | 80.13 | 35 |
GSM1296062 | M_lesional_day43 | 37.68 | 27 |
GSM1296068 | Q_lesional_day43 | 74.67 | 33 |
GSM1296050 | C_lesional_day43 | 70.08 | 35 |
GSM1296057 | D_lesional_day43 | 54.15 | 33 |
GSM1296052 | I_lesional_day43 | 70.89 | 38 |
GSM1296054 | J_lesional_day43 | 95.95 | 40 |
GSM1296049 | K_lesional_day43 | 51.22 | 31 |
GSM1296055 | W_lesional_day43 | 35.66 | 25 |
GSM1296053 | X_lesional_day43 | 51.4 | 31 |
GSM1296058 | Z_lesional_day43 | 58.72 | 35 |
GSM1296051 | F_lesional_day43 | 38.22 | 27 |
GSM1296056 | O_lesional_day43 | 51.85 | 33 |
GSM1296065 | S_lesional_day43 | 64.23 | 34 |
GSM1296061 | T_lesional_day43 | 30.55 | 23 |
GSM1296095 | A_non-lesional_pre-dose | 53.01 | 32 |
GSM1296120 | B_non-lesional_pre-dose | 62.77 | 32 |
GSM1296077 | C_non-lesional_pre-dose | 62.86 | 35 |
GSM1296093 | D_non-lesional_pre-dose | 64.86 | 34 |
GSM1296104 | E_non-lesional_pre-dose | 28.49 | 22 |
GSM1296079 | F_non-lesional_pre-dose | 55.84 | 33 |
GSM1296108 | G_non-lesional_pre-dose | 65.26 | 33 |
GSM1296110 | H_non-lesional_pre-dose | 64.8 | 32 |
GSM1296081 | I_non-lesional_pre-dose | 77.5 | 39 |
GSM1296091 | J_non-lesional_pre-dose | 66.03 | 36 |
GSM1296075 | K_non-lesional_pre-dose | 62.37 | 35 |
GSM1296112 | L_non-lesional_pre-dose | 73.98 | 32 |
GSM1296100 | M_non-lesional_pre-dose | 39.86 | 27 |
GSM1296087 | O_non-lesional_pre-dose | 67.19 | 38 |
GSM1296118 | P_non-lesional_pre-dose | 64.4 | 31 |
GSM1296114 | Q_non-lesional_pre-dose | 81.71 | 35 |
GSM1296097 | R_non-lesional_pre-dose | 33.82 | 26 |
GSM1296106 | S_non-lesional_pre-dose | 29.14 | 22 |
GSM1296102 | U_non-lesional_pre-dose | 34.58 | 25 |
GSM1296122 | V_non-lesional_pre-dose | 59.64 | 31 |
GSM1296089 | W_non-lesional_pre-dose | 70.1 | 35 |
GSM1296083 | X_non-lesional_pre-dose | 65.6 | 35 |
GSM1296116 | Y_non-lesional_pre-dose | 70.25 | 32 |
GSM1296085 | Z_non-lesional_pre-dose | 42.66 | 28 |